Onradivir for teens with flu A
Part of Infections, Lungs & breathing clinical trials.
This study tests an experimental antiviral pill called Onradivir for teenagers (ages 12 to 17) with uncomplicated influenza A. It aims to see if the drug can safely shorten flu symptoms and help you recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old.
- A test (like a nose swab) shows you have influenza A.
- Your temperature is 38°C (100.4°F) or higher, or it was at that level before taking fever medicine.
- You have at least one moderate or severe flu symptom such as headache, fever/chills, muscle/joint pain, or tiredness.
- You have at least one moderate or severe respiratory symptom such as cough, sore throat, or stuffy nose.
- Your flu symptoms started within the last 48 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether Apomivir works and is safe for people who likely have the flu and test positive for influenza A or B. You may help researchers learn if treating early can reduce flu illness and side effects.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
This study tests a new liquid medicine called suraxavir marboxil for children with the flu. It aims to see if the medicine safely reduces flu symptoms and helps kids recover faster.
This study tests a new antiviral pill, GP681, to prevent the flu in people who live with someone who has the flu. If you haven't gotten sick yet and are otherwise healthy, this might help keep you from catching it.
This study tests a new medicine called TRX-100 to see if it can help fight the flu. Healthy volunteers will be exposed to the influenza A virus in a controlled setting to see how the medicine works.
This study compares two versions of an antiviral medicine called Ingavirin to see how your body processes them and whether they are safe. Researchers will give you the medicine on an empty stomach and after eating to understand how food affects how your body absorbs it.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.